Skip to main content

Brain metastases from hepatocellular carcinoma: prognostic factors and outcome

Brain metastasis from HCC

Abstract

Brain metastases from hepatocellular carcinoma are extremely rare. The objectives of the current study were to assess the natural history, outcome, and possible prognostic factors in patients with brain metastases from hepatocellular carcinoma. Between 1995 and 2006, 6,919 patients with hepatocellular carcinoma were treated at Yonsei University Health System. Of those, 62 (0.9%) had a diagnosis of brain metastasis. We carried out a retrospective review of these 62 patients and performed a statistical analysis. The median age at the time patients were diagnosed with brain metastasis was 54 years. Forty-seven patients (76%) were male, and 53 patients had hepatitis B. Median time from diagnosis of hepatocellular carcinoma to brain metastasis was 18.2 months, and 5 patients had brain involvement as their initial presentation. Intracranial hemorrhage was frequently associated (54.8%) with brain metastasis. The most common presenting symptoms were motor weakness, mental change, and headache. Metastases were treated with whole-brain radiation therapy (WBRT) alone in 17 patients and gamma knife surgery alone in 10 patients. Six patients underwent surgical resection and 5 patients were treated with surgical resection followed by WBRT. Twenty-four patients (39%) received steroids only. Median survival after diagnosis of brain metastasis was 6.8 weeks (95% confidence interval: 3.8–9.8 weeks). Univariate analysis showed that treatment modality, number of brain lesions, α-fetoprotein, ECOG performance score, recursive partitioning analysis (RPA) class, and Child-Pugh classification had a statistically significant impact on survival. In multivariate analysis, treatment modality, number of brain lesions, and Child-Pugh classification were statistically significant prognostic factors for survival. The overall prognosis of patients with brain metastases from hepatocellular carcinoma is extremely poor. Nevertheless, some subsets of patients manifested the most favorable survival criteria (single brain metastasis and good liver function); thus, for at least these patients, treatment may result in an improved survival time.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

References

  1. El-Serag HB, Davila JA, Petersen NJ et al (2003) The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 139:817–823

    PubMed  Google Scholar 

  2. Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362:1907–1917. doi:10.1016/S0140-6736(03)14964-1

    PubMed  Article  Google Scholar 

  3. Korean National Statistical Office (2004) Annual report of cause of death in 2003. KNSO, Seoul

    Google Scholar 

  4. Sawaya R (2004) Intracranial metastases: current managment strategies. Blackwell Futura, Malden, MA, USA

    Google Scholar 

  5. Carr BI (2004) Hepatocellular carcinoma: current management and future trends. Gastroenterology 127(Suppl. 1):S218–S224. doi:10.1053/j.gastro.2004.09.036

    PubMed  Article  Google Scholar 

  6. Llovet JM, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37:429–442. doi:10.1053/jhep.2003.50047

    PubMed  Article  CAS  Google Scholar 

  7. Gaspar L, Scott C, Rotman M et al (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745–751. doi:10.1016/S0360-3016(96)00619-0

    PubMed  CAS  Google Scholar 

  8. Pugh RN, Murray-Lyon IM, Dawson JL et al (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60(8):646–649. doi:10.1002/bjs.1800600817

    PubMed  Article  CAS  Google Scholar 

  9. Uka K, Aikata H, Takaki S et al (2007) Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. World J Gastroenterol 13:414–420

    PubMed  Google Scholar 

  10. Lee YT, Geer DA (1987) Primary liver cancer: pattern of metastasis. J Surg Oncol 36:26–31. doi:10.1002/jso.2930360107

    PubMed  Article  CAS  Google Scholar 

  11. Seinfeld J, Wagner AS, Kleinschmidt-DeMasters BK (2006) Brain metastases from hepatocellular carcinoma in US patients. J Neurooncol 76:93–98. doi:10.1007/s11060-005-4175-3

    PubMed  Article  Google Scholar 

  12. Kim M, Na DL, Park SH et al (1998) Nervous system involvement by metastatic hepatocellular carcinoma. J Neurooncol 36:85–90. doi:10.1023/A:1005716408970

    PubMed  Article  CAS  Google Scholar 

  13. Murakami K, Nawano S, Moriyama N et al (1996) Intracranial metastases of hepatocellular carcinoma: CT and MRI. Neuroradiology 38(Suppl 1):S31–S35. doi:10.1007/BF02278115

    PubMed  Article  Google Scholar 

  14. Chen SF, Tsai NW, Lui CC et al (2007) Hepatocellular carcinoma presenting as nervous system involvement. Eur J Neurol 14:408–412. doi:10.1111/j.1468-1331.2007.01681.x

    PubMed  Article  Google Scholar 

  15. Tunc B, Filik L, Tezer-Filik I et al (2004) Brain metastasis of hepatocellular carcinoma: a case report and review of the literature. World J Gastroenterol 10:1688–1689

    PubMed  Google Scholar 

  16. Natsuizaka M, Omura T, Akaike T et al (2005) Clinical features of hepatocellular carcinoma with extrahepatic metastases. J Gastroenterol Hepatol 20:1781–1787. doi:10.1111/j.1440-1746.2005.03919.x

    PubMed  Article  Google Scholar 

  17. Chang L, Chen YL, Kao MC (2004) Intracranial metastasis of hepatocellular carcinoma: review of 45 cases. Surg Neurol 62:172–177. doi:10.1016/j.surneu.2003.10.002

    PubMed  Article  Google Scholar 

  18. Nomura F, Ohnishi K, Tanabe Y (1989) Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients. Cancer 64:1700–1707. doi:10.1002/1097-0142(19891015)64:8<1700::AID-CNCR2820640824>3.0.CO;2-Z

    PubMed  Article  CAS  Google Scholar 

  19. Akashi Y, Koreeda C, Enomoto S et al (1991) Prognosis of unresectable hepatocellular carcinoma: an evaluation based on multivariate analysis of 90 cases. Hepatology 14:262–268

    PubMed  CAS  Article  Google Scholar 

  20. Llado L, Virgili J, Figueras J et al (2000) A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization. Cancer 88:50–57. doi:10.1002/(SICI)1097-0142(20000101)88:1<50::AID-CNCR8>3.0.CO;2-I

    PubMed  Article  CAS  Google Scholar 

  21. Martins A, Cortez-Pinto H, Marques-Vidal P et al (2006) Treatment and prognostic factors in patients with hepatocellular carcinoma. Liver Int 26:680–687. doi:10.1111/j.1478-3231.2006.001285.x

    PubMed  Article  CAS  Google Scholar 

  22. Khuntia D, Brown P, Li J et al (2006) Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol 24:1295–1304. doi:10.1200/JCO.2005.04.6185

    PubMed  Article  CAS  Google Scholar 

  23. Richards GM, Khuntia D, Mehta MP (2007) Therapeutic management of metastatic brain tumors. Crit Rev Oncol Hematol 61:70–78. doi:10.1016/j.critrevonc.2006.06.012

    PubMed  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nae Choon Yoo.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Choi, H.J., Cho, B.C., Sohn, J.H. et al. Brain metastases from hepatocellular carcinoma: prognostic factors and outcome. J Neurooncol 91, 307 (2009). https://doi.org/10.1007/s11060-008-9713-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11060-008-9713-3

Keywords

  • Brain metastasis
  • Hepatocellular carcinoma
  • Prognostic factor